Paras Healthcare has raised Rs 652.5 crore from anchor investors, attracting broad participation from leading domestic and ...

Hyderabad-based Mapmygenome has announced the completion of its acquisition of Vancouver-based dnaPower Inc., a pioneer in ...

It is being launched through SynBioME – the IIT Madras-TICEL Biofoundry, which focuses on advancing biotechnology research, ...

The Central Drugs Standard Control Organisation (CDSCO), under the Drug Controller General of India (DCGI), has granted ...

Immuna Therapeutics AG inks $3 M partnership with NIMS University Rajasthan for advanced CAR-T cancer therapy access in India ...

The National Medical Commission (NMC) has recently announced a move enabling Registered Medical Practitioners (RMPs) to ...

Mankind will invest EUR 48 million for 70% stake in Armed Cell Therapeutics (ACTx) which has a pipeline of next-generation ...

India is projected to require an additional 2.6 billion sq. ft. of healthcare real estate by 2035, driven by the need for ...

AstraZeneca Pharma India has inaugurated its new corporate office in Mumbai, marking an extension of company’s presence in ...

The Indian Society for Clinical Research (ISCR) and the Centre for Health Applied Knowledge & Research Autonomy (CHAKRA), an ...

Biocon secures earliest licensed launch dates for Pebrilzo® (bPertuzumab) following global patent settlement with Genentech ...

Investors can help shape the next phase of rehabilitation care by backing models that combine clinical credibility with ...